ASI-MV.net: A Prescription Medication Monitoring Tool

描述（由申请人提供）：本申请建议开发成瘾严重程度指数-多媒体Version.net（ASI-MV）。net）提供可滥用的上市后监测。上市后监测监测表明药物滥用正在流行的社区指标。公共卫生相关性包括提供可靠和及时的数据，使卫生，执法，行业和社区领导人采取措施，以限制与药物滥用流行病相关的潜在损害。ASI-MV.net的概念建立在我们成功的、基于CD-ROM的ASI-MV之上，ASI-MV是成瘾严重程度指数（ASI）的自我管理版本。ASI-MV.net将使用互联网从进入治疗的客户那里收集实时、可靠和有效的产品特定数据。第一阶段将：（1）根据专家意见确定药剂监测工具所需的内容范围。(2)将设计高效的屏幕来收集特定产品的数据。(3)修改后的脚本将包含新的问题和屏幕，以识别特定于产品的数据。(4)将开发一个可工作的ASI-MV.net演示。最后，（5）将进行与标准访谈管理版本一致性的初步测试。第二阶段将全面开发ASI-MV.net网站，并建立其可靠性和有效性。ASI-MV.net将成为真实的收集特定产品成瘾数据问题的创新解决方案。

DESCRIPTION (provided by applicant): This application proposes development of the Addiction Severity Index-Multimedia Version.net (ASI-MV. net) to provide postmarketing surveillance of abusable, scheduled Pharmaceuticals. Postmarketing surveillance monitors indicators in the community that suggest an emerging epidemic of pharmaceutical abuse. Public health relevance includes providing reliable and timely data to allow health, law enforcement, industry, and community leaders to take steps to limit potential damage associated with an epidemic of pharmaceutical drug abuse. The ASI-MV.net concept builds on our successful, CD-ROM-based ASI-MV, a self-administered version of the Addiction Severity Index (ASI). The ASI-MV.net will use the Internet to collect real-time, reliable and valid, product-specific data from clients entering treatment. Phase I will: (1) identify the range of content required of a surveillance tool for pharmaceutical agents based on expert input. (2) Efficient screens will be designed to collect product-specific data. (3) A modified script will encompass new questions and screens to identify product-specific data. (4) A working ASI-MV.net demo will be developed. Finally, (5) an initial test of agreement with a standard, interview-administered version will be conducted. Phase II will fully develop the ASI-MV.net website and establish its reliability and validity. The ASI-MV.net will be an innovative solution to problems collecting product-specific addictions data in real time.